U.S. Food and Drug Administration (FDA) approved expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis...
FDA
The Food and Drug Administration (FDA) approved Biogen Inc's aducanumab drug using its Accelerated Approval pathway. Aducanumab targets amyloid plaque that...
The FDA approved several medications in May including the following: Infigratinib, a kinase inhibitor for adults with previously treated, unresectable...
Several molecules and indications were approved in April 2021 by FDA. Among the key approvals are the following: Accelerated approval...
Five new indications/molecules were approved by FDA in March 2021 including the following: Idecabtagene vicleucel for the treatment of adult...
Six new indications/molecules were approved by FDA in February 2021 including the following: Melphalan flufenamide in combination with dexamethasone for adult...
In January 2021, the FDA approved the following new indications/Molecules. Combination of nivolumab and cabozantinib as first-line treatment for patients...
What is Amyloidosis? An amyloidosis is a group of serious and rare diseases in which abnormal proteins, known as amyloid...
In November, three (3) indications/molecules were approved by FDA: Sonalleve MR-HIFU system for the treatment of osteoid osteoma in the...
What is B-cell lymphoma? B-cell lymphomas are a type of blood cancer that developed more frequently in immunocompromised patients and...
